Regulation	O
of	O
interleukin-2	B-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
expression	O
and	O
nuclear	B-protein
factor.kappa	I-protein
B	I-protein
activation	O
by	O
protein	B-protein
kinase	I-protein
C	I-protein
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Autocrine	O
role	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
.	O

The	O
regulation	O
of	O
interleukin-2	B-protein
receptor	I-protein
alpha	I-protein
chain	I-protein
(	O
IL-2R	B-protein
alpha	I-protein
)	O
expression	O
and	O
nuclear	B-protein
factor	I-protein
(	O
NF	O
)	O
activation	O
by	O
protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
in	O
resting	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
has	O
been	O
studied	O
.	O

Treatment	O
of	O
human	O
resting	B-cell_type
T	I-cell_type
cells	I-cell_type
with	O
phorbol	O
esters	O
strongly	O
induced	O
the	O
expression	O
of	O
IL-2R	B-protein
alpha	I-protein
and	O
the	O
activation	O
of	O
NF.kappa	B-protein
B	I-protein
.	O

This	O
activation	O
was	O
due	O
to	O
the	O
translocation	O
of	O
p65	B-protein
and	O
c-Rel	B-protein
NF.kappa	B-protein
B	I-protein
proteins	O
from	O
cytoplasmic	O
stores	O
to	O
the	O
nucleus	O
,	O
where	O
they	O
bound	O
the	O
kappa	B-DNA
B	I-DNA
sequence	I-DNA
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
promoter	I-DNA
either	O
as	O
p50.p65	B-protein
or	O
as	O
p50.c-Rel	B-protein
heterodimers	O
.	O

Interestingly	O
,	O
all	O
of	O
those	O
events	O
were	O
largely	O
indirect	O
and	O
mediated	O
by	O
endogenously	O
secreted	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF	B-protein
alpha	I-protein
)	O
,	O
as	O
they	O
were	O
strongly	O
inhibited	O
by	O
a	O
neutralizing	B-protein
anti-TNF	I-protein
alpha	I-protein
monoclonal	I-protein
antibody	I-protein
.	O

Furthermore	O
,	O
cyclosporin	O
A	O
,	O
which	O
blocked	O
TNF	B-protein
alpha	I-protein
production	O
induced	O
by	O
PKC	B-protein
,	O
strongly	O
inhibited	O
IL-2R	B-protein
alpha	I-protein
and	O
NF.kappa	B-protein
B	I-protein
activation	O
.	O

The	O
addition	O
of	O
either	O
TNF	B-protein
alpha	I-protein
or	O
IL-2	B-protein
partially	O
recovered	O
cyclosporin	O
A-induced	O
IL-2R	B-protein
alpha	I-protein
inhibition	O
,	O
but	O
only	O
TNF	B-protein
alpha	I-protein
completely	O
recovered	O
NF.kappa	B-protein
B	I-protein
activation	O
.	O

Those	O
results	O
indicate	O
that	O
,	O
in	O
resting	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
PKC	B-protein
activation	O
has	O
only	O
a	O
triggering	O
role	O
,	O
whereas	O
the	O
endogenously	O
secreted	O
TNF	B-protein
alpha	I-protein
plays	O
an	O
essential	O
role	O
in	O
the	O
quantitative	O
control	O
of	O
the	O
expression	O
of	O
IL-2R	B-protein
alpha	I-protein
chain	O
or	O
NF.kappa	B-protein
B	I-protein
activation	O
.	O

Tez	NULL
Journar	NULL
or	NULL
Broocicat	NULL
CrEnistay	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

39	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
30	NULL
,	NULL
pp	NULL
.	NULL

24424-24429	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Regulation	NULL
of	NULL
Interleukin-2	NULL
Receptor	NULL
a	NULL
Chain	NULL
Expression	NULL
and	NULL
Nuclear	NULL
Factor-	NULL
«	NULL
B	NULL
Activation	NULL
by	NULL
Protein	NULL
Kinase	NULL
C	NULL
in	NULL
T	NULL
Lymphocytes	NULL
AUTOCRINE	NULL
ROLE	NULL
OF	NULL
TUMOR	NULL
NECROSIS	NULL
FACTOR	NULL
a*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
6	NULL
,	NULL
1994	NULL
)	NULL
Felipe	NULL
X.	NULL
Pimentel-Muinios	NULL
,	NULL
Javier	NULL
Mazana	NULL
,	NULL
and	NULL
Manuel	NULL
Fresnot	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas	NULL
,	NULL
Universidad	NULL
Autonoma	NULL
Madrid	NULL
,	NULL
28049	NULL
Madrid	NULL
,	NULL
Spain	NULL
The	NULL
regulation	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
(	NULL
IL-2Ra	NULL
)	NULL
expression	NULL
and	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
activation	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
has	NULL
been	NULL
stud-ied	NULL
.	NULL

Treatment	NULL
of	NULL
human	NULL
resting	NULL
T	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
strongly	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
«	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

This	NULL
activation	NULL
was	NULL
due	NULL
to	NULL
the	NULL
translocation	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
NF-	NULL
<	NULL
B	NULL
proteins	NULL
from	NULL
cytoplasmic	NULL
stores	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
bound	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
either	NULL
as	NULL
p50-p65	NULL
or	NULL
as	NULL
p50-c-Rel	NULL
heterodimers	NULL
.	NULL

Interestingly	NULL
,	NULL
all	NULL
of	NULL
those	NULL
events	NULL
were	NULL
largely	NULL
indirect	NULL
and	NULL
mediated	NULL
by	NULL
endogenously	NULL
secreted	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNFa	NULL
)	NULL
,	NULL
as	NULL
they	NULL
were	NULL
strongly	NULL
inhibited	NULL
by	NULL
a	NULL
neutralizing	NULL
anti-INFa	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Furthermore	NULL
,	NULL
cyclosporin	NULL
A	NULL
,	NULL
which	NULL
blocked	NULL
TNFa	NULL
production	NULL
induced	NULL
by	NULL
PKC	NULL
,	NULL
strongly	NULL
inhibited	NULL
IL-2Ra	NULL
«	NULL
and	NULL
NF	NULL
-B	NULL
activation	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
either	NULL
TNFa	NULL
or	NULL
IL-2	NULL
partially	NULL
recovered	NULL
cyclosporin	NULL
A-induced	NULL
IL-2R	NULL
«	NULL
inhibition	NULL
,	NULL
but	NULL
only	NULL
TNFa	NULL
completely	NULL
recovered	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Those	NULL
results	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
PKC	NULL
activation	NULL
has	NULL
only	NULL
a	NULL
triggering	NULL
role	NULL
,	NULL
whereas	NULL
the	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
quantitative	NULL
control	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
or	NULL
NF	NULL
-B	NULL
activation	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
is	NULL
a	NULL
complex	NULL
event	NULL
that	NULL
triggers	NULL
several	NULL
early	NULL
intracellular	NULL
sig-nals	NULL
,	NULL
such	NULL
as	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
the	NULL
rise	NULL
of	NULL
the	NULL
cytosolic	NULL
Ca®*	NULL
concentration	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
serine/threonine	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
activation	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
the	NULL
simultaneous	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
and	NULL
Ca**	NULL
ionophores	NULL
(	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
PKC	NULL
activation	NULL
and	NULL
intracellular	NULL
Ca*	NULL
rise	NULL
are	NULL
sufficient	NULL
signals	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
.	NULL

Those	NULL
TCR-transduced	NULL
signals	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
the	NULL
membrane	NULL
expression	NULL
of	NULL
high	NULL
affinity	NULL
IL-2	NULL
receptors	NULL
(	NULL
IL-2Rs	NULL
)	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Later	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
two	NULL
molecules	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
T	NULL
cells	NULL
elicits	NULL
a	NULL
distinct	NULL
set	NULL
of	NULL
signals	NULL
that	NULL
induces	NULL
the	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

High	NULL
affinity	NULL
IL-2Rs	NULL
are	NULL
composed	NULL
of	NULL
at	NULL
least	NULL
three	NULL
chains	NULL
,	NULL
a	NULL
,	NULL
B	NULL
and	NULL
y	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
Direccion	NULL
General	NULL
de	NULL
In-vestigacion	NULL
Cientifica	NULL
y	NULL
Técnica	NULL
and	NULL
from	NULL
Fundacion	NULL
Ramon	NULL
Areces	NULL
,	NULL
and	NULL
Antibioticos	NULL
Farma	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Tel	NULL
.	NULL

:	NULL
;	NULL
341-397-8413	NULL
;	NULL
Fax	NULL
:	NULL
341-3974799	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
EMSAs	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IL-2R	NULL
,	NULL
interleukin-2	NULL
receptor	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
PDB	NULL
,	NULL
phorbol	NULL
12,13-dibutyrate	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
SRF	NULL
,	NULL
serum-responsive	NULL
factor	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
CAPS	NULL
,	NULL
3-	NULL
(	NULL
cyelohex-ylamino	NULL
)	NULL
propanesulfonic	NULL
acid	NULL
.	NULL

resting	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
«	NULL
chain	NULL
is	NULL
induced	NULL
de	NULL
novo	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
through	NULL
TCR	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
PKC	NULL
activation	NULL
is	NULL
enough	NULL
to	NULL
induce	NULL
IL-2Ra	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
contains	NULL
one	NULL
consensus	NULL
site	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
ubiquitous	NULL
family	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
(	NULL
NF	NULL
)	NULL
:	NULL
«	NULL
B	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
(	NULL
12	NULL
,	NULL
13-18	NULL
)	NULL
.	NULL

NF	NULL
-	NULL
«	NULL
B	NULL
are	NULL
composed	NULL
by	NULL
hetero-	NULL
and	NULL
homodimers	NULL
of	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
include	NULL
the	NULL
dorsal	NULL
gene	NULL
of	NULL
Drosophila	NULL
and	NULL
the	NULL
mammalian	NULL
genes	NULL
nf	NULL
%	NULL
B1	NULL
,	NULL
c-rel	NULL
,	NULL
rel	NULL
A	NULL
,	NULL
and	NULL
rel	NULL
B	NULL
,	NULL
all	NULL
of	NULL
them	NULL
involved	NULL
in	NULL
gene	NULL
regulation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
subunit	NULL
composition	NULL
of	NULL
the	NULL
different	NULL
complexes	NULL
defines	NULL
the	NULL
fine	NULL
specificity	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
target	NULL
sequences	NULL
and	NULL
their	NULL
transactivating	NULL
activity	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

All	NULL
members	NULL
share	NULL
a	NULL
homologous	NULL
300-amino	NULL
acid	NULL
region	NULL
containing	NULL
the	NULL
essential	NULL
domains	NULL
for	NULL
their	NULL
activity	NULL
:	NULL
the	NULL
DNA-binding	NULL
domain	NULL
,	NULL
the	NULL
dimerization	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
factors	NULL
are	NULL
present	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
uninduced	NULL
cells	NULL
,	NULL
retained	NULL
by	NULL
another	NULL
family	NULL
of	NULL
proteins	NULL
termed	NULL
IkB	NULL
that	NULL
contain	NULL
ankyrin	NULL
repeats	NULL
as	NULL
common	NULL
structural	NULL
motif	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
growth	NULL
factors	NULL
or	NULL
different	NULL
activators	NULL
,	NULL
those	NULL
IxBs	NULL
suffer	NULL
postranscriptional	NULL
modifications	NULL
(	NULL
such	NULL
as	NULL
phosphorylation	NULL
)	NULL
,	NULL
that	NULL
induce	NULL
them	NULL
to	NULL
dissociate	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
allowing	NULL
its	NULL
transport	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
concomitant	NULL
activation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
by	NULL
PKC	NULL
or	NULL
through	NULL
TCR	NULL
,	NULL
TNF-receptors	NULL
,	NULL
or	NULL
CD28	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
inducing	NULL
this	NULL
nuclear	NULL
translocation	NULL
(	NULL
24-29	NULL
)	NULL
.	NULL

TNFa	NULL
is	NULL
a	NULL
cytokine	NULL
mainly	NULL
produced	NULL
by	NULL
activated	NULL
macro-phages	NULL
(	NULL
30	NULL
)	NULL
,	NULL
although	NULL
it	NULL
is	NULL
also	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
several	NULL
stimuli	NULL
including	NULL
phorbol	NULL
esters	NULL
(	NULL
30-33	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
TNFa	NULL
induces	NULL
IL-2Ra	NULL
expression	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
way	NULL
similar	NULL
to	NULL
phorbol	NULL
esters	NULL
(	NULL
10	NULL
,	NULL
24-26	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
described	NULL
that	NULL
TNFa	NULL
induces	NULL
the	NULL
proliferation	NULL
of	NULL
suboptimally	NULL
stimulated	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
IL-2/IL-2R	NULL
pathway	NULL
(	NULL
35-37	NULL
)	NULL
and	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
a	NULL
TNFa-dependent	NULL
increase	NULL
of	NULL
IL-Z2Ra	NULL
«	NULL
expression	NULL
(	NULL
34-37	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recent	NULL
results	NULL
from	NULL
our	NULL
laboratory	NULL
indicate	NULL
that	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
plays	NULL
a	NULL
very	NULL
important	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
through	NULL
TCR/CD3	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
address	NULL
the	NULL
question	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
IL-2Ra	NULL
expression	NULL
by	NULL
PKC	NULL
in	NULL
a	NULL
physiological	NULL
system	NULL
such	NULL
as	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
implication	NULL
of	NULL
endogenously	NULL
secreted	NULL
lymphokines	NULL
in	NULL
those	NULL
processes	NULL
was	NULL
also	NULL
investigated	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Phorbol	NULL
12,13-dibutyrate	NULL
(	NULL
PDB	NULL
)	NULL
and	NULL
staurosporine	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
,	NULL
and	NULL
CsA	NULL
was	NULL
obtained	NULL
from	NULL
Sandoz	NULL
Pharmaceutical	NULL
Co.	NULL
(	NULL
Hanover	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Recombinant	NULL
IL-2	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
En-dogen	NULL
(	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
and	NULL
recombinant	NULL
TNFa	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Antibisticos	NULL
Farma	NULL
(	NULL
Madrid	NULL
)	NULL
.	NULL

The	NULL
neutralizing	NULL
anti-TNF	NULL
«	NULL
mAb	NULL
,	NULL
B13.2	NULL
,	NULL
was	NULL
developed	NULL
in	NULL
our	NULL
lab-oratory	NULL
.	NULL

It	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
lymphotoxin	NULL
(	NULL
TNFR	NULL
)	NULL
and	NULL
it	NULL
is	NULL
able	NULL
24424	NULL
Regulation	NULL
of	NULL
IL-2Ra	NULL
and	NULL
NF-kB	NULL
by	NULL
PKC	NULL
in	NULL
T	NULL
Cells	NULL
to	NULL
neutralize	NULL
the	NULL
cytotoxic	NULL
and	NULL
T	NULL
cell	NULL
costimulatory	NULL
activity	NULL
of	NULL
TNF	NULL
«	NULL
.	NULL
``	NULL

It	NULL
was	NULL
purified	NULL
from	NULL
ascitic	NULL
fluid	NULL
.	NULL

The	NULL
MAR	NULL
108	NULL
mAb	NULL
(	NULL
87	NULL
)	NULL
is	NULL
specific	NULL
for	NULL
IL-2Ra	NULL
chain	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
culture	NULL
supernatant	NULL
for	NULL
cytofluorometric	NULL
analyses	NULL
or	NULL
as	NULL
purified	NULL
antibody	NULL
for	NULL
IL-2-neutralizing	NULL
activity	NULL
.	NULL

The	NULL
anti-p50	NULL
NF-	NULL
«	NULL
B	NULL
rabbit	NULL
serum	NULL
(	NULL
Serum	NULL
2	NULL
(	NULL
39	NULL
)	NULL
)	NULL
,	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
Alain	NULL
Israél	NULL
.	NULL

The	NULL
anti-c-Rel	NULL
(	NULL
Serum	NULL
1136	NULL
(	NULL
17	NULL
)	NULL
and	NULL
Serum	NULL
265	NULL
)	NULL
,	NULL
the	NULL
anti-p65	NULL
(	NULL
Serum	NULL
1226	NULL
)	NULL
,	NULL
and	NULL
the	NULL
anti-p50	NULL
(	NULL
Serum	NULL
1141	NULL
)	NULL
rabbit	NULL
sera	NULL
,	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Nancy	NULL
Rice	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Cell	NULL
Cultures-Human	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
whole	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
centrifugation	NULL
on	NULL
Ficoll	NULL
Hypaque	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Inc.	NULL
)	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
adherence	NULL
to	NULL
plastic	NULL
dishes	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
passing	NULL
the	NULL
nonadherent	NULL
population	NULL
through	NULL
a	NULL
nylon	NULL
fiber	NULL
wool	NULL
column	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
this	NULL
population	NULL
(	NULL
assayed	NULL
by	NULL
flow	NULL
cytometry	NULL
)	NULL
,	NULL
was	NULL
always	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
CD3+*	NULL
cells	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
(	NULL
10®/ml	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
)	NULL
were	NULL
activated	NULL
with	NULL
different	NULL
stimuli	NULL
as	NULL
indicated	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

The	NULL
neutralizing	NULL
anti-TNFa	NULL
and	NULL
anti-IL-2Ra	NULL
antibodies	NULL
and	NULL
the	NULL
drugs	NULL
CsA	NULL
and	NULL
staurosporine	NULL
,	NULL
when	NULL
used	NULL
,	NULL
were	NULL
present	NULL
in	NULL
the	NULL
cell	NULL
culture	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
any	NULL
other	NULL
stimuli	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
staurosporine	NULL
,	NULL
a	NULL
preincubation	NULL
of	NULL
1	NULL
h	NULL
was	NULL
carried	NULL
out	NULL
.	NULL

None	NULL
of	NULL
the	NULL
reagents	NULL
affected	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
cells	NULL
at	NULL
the	NULL
concentrations	NULL
used	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
test	NULL
.	NULL

Cytofluorometric	NULL
Analysis-The	NULL
surface	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
chain	NULL
(	NULL
CD25	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
immunofluorescence	NULL
in	NULL
an	NULL
EPICS-C	NULL
cytoflu-orometer	NULL
(	NULL
Coulter	NULL
Scientific	NULL
,	NULL
Harpenden	NULL
,	NULL
GB	NULL
)	NULL
.	NULL

For	NULL
this	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
the	NULL
indicated	NULL
stimuli	NULL
in	NULL
96-well	NULL
plastic	NULL
plates	NULL
.	NULL

After	NULL
40	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
treated	NULL
with	NULL
buffer	NULL
glycine	NULL
(	NULL
pH	NULL
2	NULL
)	NULL
in	NULL
order	NULL
to	NULL
eliminate	NULL
any	NULL
possible	NULL
bound	NULL
antibody	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
hybridoma	NULL
MAR	NULL
108	NULL
culture	NULL
supernatant	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
and	NULL
labeling	NULL
with	NULL
fluorescein-labeled	NULL
rabbit	NULL
anti-mouse	NULL
immunoglobulin	NULL
,	NULL
as	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

mRNA	NULL
Detection-Specific	NULL
mRNA	NULL
levels	NULL
were	NULL
quantified	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
obtained	NULL
from	NULL
T	NULL
cells	NULL
after	NULL
the	NULL
indicated	NULL
incubations	NULL
,	NULL
as	NULL
described	NULL
by	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
between	NULL
5	NULL
and	NULL
8	NULL
ug	NULL
)	NULL
of	NULL
RNA	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
a	NULL
denaturing	NULL
formaldehyde	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond-N	NULL
,	NULL
Amersham	NULL
Corp.	NULL
)	NULL
as	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
hybridizations	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
T	NULL
cells	NULL
essentially	NULL
by	NULL
the	NULL
previously	NULL
described	NULL
method	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
reported	NULL
(	NULL
38	NULL
)	NULL
,	NULL
using	NULL
as	NULL
labeled	NULL
probe	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
of	NULL
IL-2Ra	NULL
promoter	NULL
region	NULL
(	NULL
5'-GCT-CACCCTACCTTCAACGGCAGGGGAATCTCCCTCTCCTTTTATGGG-	NULL
(	NULL
44	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
«	NULL
B	NULL
element	NULL
and	NULL
surrounding	NULL
sequences	NULL
.	NULL

The	NULL
binding	NULL
complexes	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
5	NULL
%	NULL
acrylamide	NULL
gel	NULL
,	NULL
and	NULL
their	NULL
specificity	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
50x	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
AP2	NULL
(	NULL
5-GATCGAACTGACCGC-CCGCGGCCCGT-3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
-270	NULL
to	NULL
-253	NULL
fragment	NULL
of	NULL
IL-2Re	NULL
promoter	NULL
(	NULL
«	NULL
B-like	NULL
element	NULL
:	NULL
55-GCAGGGGAATCTCCCTCT-3	NULL
'	NULL
)	NULL
,	NULL
immunoglobulin	NULL
xB	NULL
(	NULL
5'-AGTTGAGGGGACTTTCCCAGGC-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
the	NULL
serum-responsive	NULL
element	NULL
also	NULL
included	NULL
in	NULL
IL-2Ra	NULL
promoter	NULL
,	NULL
flanked	NULL
by	NULL
HindIII	NULL
and	NULL
Sall	NULL
restriction	NULL
sites	NULL
(	NULL
5'-AGCTTTCTCCTTTTATGGGCGTAG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
composition	NULL
of	NULL
each	NULL
DNA-protein	NULL
complex	NULL
was	NULL
identified	NULL
by	NULL
supershifting	NULL
assays	NULL
using	NULL
specific	NULL
anti-NF-	NULL
«	NULL
B	NULL
polyclonal	NULL
rabbit	NULL
antisera	NULL
.	NULL

These	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
normal	NULL
EMSAs	NULL
,	NULL
except	NULL
that	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
different	NULL
anti-NF-	NULL
«	NULL
B	NULL
antisera	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extract	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Western	NULL
Blot	NULL
Assays-The	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
as	NULL
described	NULL
above	NULL
(	NULL
43	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
supernatants	NULL
of	NULL
the	NULL
pelleted	NULL
nuclei	NULL
were	NULL
considered	NULL
cytoplasmic	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
or	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
8	NULL
ng	NULL
)	NULL
obtained	NULL
from	NULL
T	NULL
cells	NULL
incubated	NULL
under	NULL
the	NULL
different	NULL
conditions	NULL
,	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
10	NULL
%	NULL
discontinuous	NULL
polyacrilamide	NULL
minigel	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Milli-pore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
using	NULL
10	NULL
mm	NULL
CAPS	NULL
(	NULL
pH	NULL
11	NULL
)	NULL
as	NULL
transferring	NULL
buffer	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
saturated	NULL
by	NULL
incubation	NULL
at	NULL
4	NULL
°C	NULL
overnight	NULL
with	NULL
10	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
and	NULL
then	NULL
they	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
different	NULL
anti-NF-	NULL
«	NULL
B	NULL
antibodies	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
they	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
anti-rabbit	NULL
immunoglobulin	NULL
coupled	NULL
to	NULL
peroxidase	NULL
,	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
several	NULL
washes	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
Amersham	NULL
ECL	NULL
chemiluminiscence	NULL
method	NULL
.	NULL

*	NULL
M.	NULL
A.	NULL
Mufioz-Ferngndez	NULL
,	NULL
F.	NULL
X.	NULL
Pimentel-Muifios	NULL
,	NULL
and	NULL
M.	NULL
Fresno	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

24425	NULL
Vo	NULL
2	NULL
MF	NULL
7	NULL
MEDIUM	NULL
+	NULL
%	NULL
710	NULL
MF	NULL
13	NULL
POB	NULL
;	NULL
%	NULL
26	NULL
MF	NULL
7	NULL
PDB	NULL
+	NULL
anti-	NULL
TNF	NULL
Number	NULL
of	NULL
cells	NULL
y	NULL
%	NULL
19	NULL
MF	NULL
6	NULL
PDB	NULL
+	NULL
anti-IL	NULL
-	NULL
2R	NULL
<	NULL
t	NULL
Ig	NULL
fluorescence	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
endogenous	NULL
TNF	NULL
«	NULL
and	NULL
IL-2	NULL
on	NULL
membrane	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
activated	NULL
with	NULL
PDB	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
in	NULL
presence	NULL
of	NULL
PDB	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
anti-IL-2Ra	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
anti-TNFa	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
during	NULL
40	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
stained	NULL
with	NULL
specific	NULL
anti-IL-2Ra	NULL
mAb	NULL
,	NULL
and	NULL
their	NULL
fluorescence	NULL
was	NULL
quantified	NULL
by	NULL
flow	NULL
cytom-etry	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
and	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
fluorescence	NULL
(	NULL
MF	NULL
)	NULL
of	NULL
these	NULL
positive	NULL
cells	NULL
are	NULL
shown	NULL
.	NULL

RESULTS	NULL
IL-2R	NULL
«	NULL
induction	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
two	NULL
of	NULL
the	NULL
most	NULL
important	NULL
events	NULL
triggered	NULL
by	NULL
PKC	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
10	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
TNFa	NULL
and	NULL
phorbol	NULL
esters	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
are	NULL
remarkably	NULL
similar	NULL
(	NULL
10	NULL
,	NULL
24-26	NULL
,	NULL
34	NULL
)	NULL
.	NULL

As	NULL
TNFa	NULL
synthesis	NULL
is	NULL
induced	NULL
by	NULL
PKC	NULL
activators	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
part	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
PKC	NULL
activation	NULL
could	NULL
be	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
mediated	NULL
by	NULL
this	NULL
cytokine	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
on	NULL
PDB-triggered	NULL
IL-2Ra	NULL
expression	NULL
in	NULL
the	NULL
membrane	NULL
of	NULL
T	NULL
cells	NULL
using	NULL
a	NULL
neutralizing	NULL
anti-TNFa	NULL
«	NULL
mAb	NULL
to	NULL
inhibit	NULL
its	NULL
action	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

PDB	NULL
induced	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
human	NULL
purified	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
40	NULL
h	NULL
after	NULL
activation	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
expression	NULL
was	NULL
strongly	NULL
inhibited	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
neutralizing	NULL
anti-TNFa	NULL
or	NULL
anti-IL-2Ra	NULL
mAbs	NULL
,	NULL
indicating	NULL
that	NULL
PKC	NULL
activation	NULL
by	NULL
itself	NULL
has	NULL
a	NULL
very	NULL
small	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
and	NULL
suggesting	NULL
that	NULL
its	NULL
effect	NULL
is	NULL
in	NULL
fact	NULL
mediated	NULL
by	NULL
the	NULL
autocrine	NULL
action	NULL
of	NULL
IL-2	NULL
and	NULL
TNFa	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
know	NULL
if	NULL
those	NULL
changes	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
reflected	NULL
changes	NULL
in	NULL
the	NULL
mRNA	NULL
levels	NULL
.	NULL

Treatment	NULL
of	NULL
purified	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
PDB	NULL
resulted	NULL
in	NULL
a	NULL
strong	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
mRNAs	NULL
specific	NULL
for	NULL
IL-2Ra	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
which	NULL
peaked	NULL
at	NULL
20	NULL
h	NULL
after	NULL
PKC	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
strongly	NULL
inhibited	NULL
(	NULL
ranging	NULL
70-80	NULL
%	NULL
depending	NULL
on	NULL
the	NULL
donor	NULL
of	NULL
cells	NULL
)	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
neutralizing	NULL
anti-TNFa	NULL
or	NULL
anti-IL-2Ra	NULL
«	NULL
mAbs	NULL
in	NULL
the	NULL
cell	NULL
cultures	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
almost	NULL
as	NULL
good	NULL
as	NULL
the	NULL
one	NULL
obtained	NULL
with	NULL
the	NULL
PKC	NULL
inhibitor	NULL
staurosporine	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
in	NULL
a	NULL
different	NULL
way	NULL
the	NULL
exact	NULL
contribution	NULL
of	NULL
the	NULL
autocrine	NULL
secretion	NULL
of	NULL
IL-2	NULL
and	NULL
TNFa	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
IL-2Ra	NULL
,	NULL
we	NULL
inhibited	NULL
their	NULL
production	NULL
with	NULL
the	NULL
drug	NULL
CsA	NULL
and	NULL
supplemented	NULL
the	NULL
cultures	NULL
with	NULL
exogenous	NULL
lymphokines	NULL
.	NULL

This	NULL
drug	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
coding	NULL
for	NULL
several	NULL
lymphokines	NULL
without	NULL
directly	NULL
affecting	NULL
those	NULL
coding	NULL
for	NULL
their	NULL
receptors	NULL
(	NULL
45	NULL
)	NULL
.	NULL

PDB	NULL
induced	NULL
the	NULL
secretion	NULL
of	NULL
TNFa	NULL
and	NULL
low	NULL
amounts	NULL
of	NULL
IL-2	NULL
by	NULL
human	NULL
purified	NULL
T	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
,	NULL
which	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
CsA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
mRNA	NULL
expression	NULL
by	NULL
PDB	NULL
was	NULL
also	NULL
24426	NULL
PDB	NULL
s	NULL
s	NULL
__	NULL
PDB	NULL
antiTNFa	NULL
3	NULL
-	NULL
+	NULL
-	NULL
-	NULL
CsA	NULL
S	NULL
-	NULL
1	NULL
.	NULL

.	NULL

.	NULL

anti-lL-2Ra	NULL
-	NULL
&	NULL
-	NULL
£0	NULL
TNFa	NULL
@	NULL
a	NULL
-	NULL
%	NULL
Staurosporine	NULL
2	NULL
-	NULL
noo	NULL
LG	NULL
&	NULL
.	NULL

P	NULL
IL-2Ra	NULL
-	NULL
»	NULL
]	NULL
(	NULL
IL-2R	NULL
«	NULL
-	NULL
»	NULL
|	NULL
_	NULL
IL-2Ra	NULL
-	NULL
»	NULL
6	NULL
%	NULL
IL-2Ra	NULL
-	NULL
»	NULL
‘	NULL
vq	NULL
0	NULL
__0.2	NULL
__	NULL
0	NULL
o	NULL
0.1	NULL
0.6	NULL
1	NULL
0.1	NULL
1T	NULL
~	NULL
64	NULL
fi	NULL
288	NULL
285	NULL
-	NULL
ewnee|	NULL
=	NULL
--	NULL
anssse	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
endogenous	NULL
TNFa	NULL
and	NULL
IL-2	NULL
on	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
expression	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
activated	NULL
with	NULL
PDB	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PDB	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
anti-IL-2Ra	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-TNFa	NULL
«	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
staurosporine	NULL
(	NULL
50	NULL
n	NULL
)	NULL
,	NULL
CsA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
20	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
TNFa	NULL
(	NULL
500	NULL
units/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
during	NULL
20	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
obtained	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
it	NULL
were	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
assays	NULL
using	NULL
an	NULL
IL-2Ra-specific	NULL
*P-radiola-beled	NULL
probe	NULL
.	NULL

All	NULL
membranes	NULL
were	NULL
rehybridized	NULL
with	NULL
a	NULL
specific	NULL
28	NULL
S	NULL
rRNA	NULL
probe	NULL
(	NULL
as	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
figure	NULL
)	NULL
and	NULL
scanned	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
film	NULL
.	NULL

The	NULL
absorbance	NULL
values	NULL
shown	NULL
under	NULL
each	NULL
lane	NULL
were	NULL
corrected	NULL
with	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
rRNA	NULL
in	NULL
each	NULL
lane	NULL
and	NULL
standarized	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
control	NULL
lane	NULL
.	NULL

inhibited	NULL
(	NULL
80-90	NULL
%	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
drug	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

This	NULL
expression	NULL
could	NULL
be	NULL
partially	NULL
recovered	NULL
by	NULL
the	NULL
exogenous	NULL
addition	NULL
of	NULL
either	NULL
TNFa	NULL
or	NULL
IL-2	NULL
and	NULL
totally	NULL
rescued	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
both	NULL
lymphokines	NULL
together	NULL
.	NULL

Those	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
autocrine	NULL
action	NULL
of	NULL
both	NULL
lymphokines	NULL
plays	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
«	NULL
chain	NULL
of	NULL
the	NULL
IL-2R	NULL
by	NULL
PKC	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
have	NULL
a	NULL
relevant	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
(	NULL
12-18	NULL
)	NULL
,	NULL
is	NULL
another	NULL
typical	NULL
event	NULL
that	NULL
occurs	NULL
upon	NULL
PKC	NULL
activation	NULL
or	NULL
TNFa	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
induced	NULL
by	NULL
PKC	NULL
activation	NULL
could	NULL
be	NULL
mediating	NULL
the	NULL
PKC-triggered	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
PDB	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
neutralizing	NULL
anti-TNFa	NULL
«	NULL
mAb	NULL
or	NULL
CsA	NULL
.	NULL

Those	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
approximately	NULL
5-6	NULL
h	NULL
before	NULL
the	NULL
maximum	NULL
synthesis	NULL
of	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
in	NULL
order	NULL
to	NULL
look	NULL
for	NULL
a	NULL
possible	NULL
correlation	NULL
between	NULL
both	NULL
phenomena	NULL
.	NULL

The	NULL
-290	NULL
to	NULL
-239	NULL
oligonucleotide	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
IL-2Ra	NULL
«	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
a	NULL
«	NULL
B	NULL
element	NULL
and	NULL
other	NULL
surrounding	NULL
sequences	NULL
that	NULL
have	NULL
also	NULL
been	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
(	NULL
15	NULL
,	NULL
18	NULL
,	NULL
44	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
different	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
assayed	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
probe	NULL
or	NULL
the	NULL
unrelated	NULL
oligonucleotide	NULL
AP2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Four	NULL
specific	NULL
complexes	NULL
of	NULL
the	NULL
probe	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
PDB-activated	NULL
T	NULL
cells	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
each	NULL
complex	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
two	NULL
internal	NULL
oligonucleotides	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
identified	NULL
as	NULL
being	NULL
recognized	NULL
by	NULL
nuclear	NULL
factors	NULL
:	NULL
serum-responsive	NULL
element	NULL
and	NULL
kB	NULL
elements	NULL
(	NULL
44	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
upper	NULL
band	NULL
was	NULL
efficiently	NULL
competed	NULL
by	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
and	NULL
by	NULL
the	NULL
serum-responsive	NULL
IL-2Ra	NULL
«	NULL
element	NULL
(	NULL
-256	NULL
to	NULL
-239	NULL
)	NULL
but	NULL
not	NULL
by	NULL
AP2-	NULL
or	NULL
«	NULL
B-related	NULL
oligonucleotides	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
serum-responsive	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
to	NULL
the	NULL
-256	NULL
to	NULL
--	NULL
239	NULL
fragment	NULL
.	NULL

However	NULL
,	NULL
the	NULL
three	NULL
lower	NULL
bands	NULL
were	NULL
competed	NULL
by	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
oligonucleotide	NULL
,	NULL
the	NULL
kB	NULL
IL-2Ra	NULL
«	NULL
element	NULL
(	NULL
-270	NULL
to	NULL
-253	NULL
)	NULL
or	NULL
the	NULL
immunoglobulin	NULL
«	NULL
B	NULL
one	NULL
,	NULL
but	NULL
not	NULL
by	NULL
AP2	NULL
or	NULL
the	NULL
serum-responsive	NULL
IL-2Ra	NULL
«	NULL
element	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
formed	NULL
by	NULL
NF-	NULL
«	NULL
B-related	NULL
proteins	NULL
recognizing	NULL
the	NULL
-270	NULL
to	NULL
-253	NULL
IL-2Ra	NULL
«	NULL
element	NULL
.	NULL

The	NULL
nucleus	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
only	NULL
contained	NULL
the	NULL
SRF	NULL
factor	NULL
and	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
NF	NULL
-	NULL
«	NULL
kB	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
PDB	NULL
Regulation	NULL
of	NULL
IL-2Ra	NULL
and	NULL
NF-kB	NULL
by	NULL
PKC	NULL
in	NULL
T	NULL
Cells	NULL
a	NULL
&	NULL
O	NULL
a	NULL
o	NULL
2	NULL
&	NULL
C	NULL
&	NULL
3	NULL
3	NULL
DNA	NULL
competitor	NULL
2	NULL
g	NULL
a	NULL
§	NULL
§	NULL
Q	NULL
50x	NULL
2	NULL
R	NULL
&	NULL
&	NULL
J	NULL
_	NULL
p	NULL
Y	NULL
<	NULL
d	NULL
-J	NULL
P	NULL
St	NULL
-	NULL
»	NULL
|	NULL
#	NULL
#	NULL
-	NULL
gad	NULL
=	NULL
soins	NULL
NF	NULL
.	NULL

«	NULL
8	NULL
-f	NULL
NF	NULL
.	NULL

xB	NULL
-t	NULL
free	NULL
probe	NULL
-	NULL
»	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

DNA-protein	NULL
complexes	NULL
from	NULL
PDB-activated	NULL
T	NULL
cells	NULL
obtained	NULL
with	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
of	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PDB	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

during	NULL
16	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
,	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
(	NULL
**P-labeled	NULL
)	NULL
of	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
the	NULL
binding	NULL
assays	NULL
were	NULL
preincubated	NULL
in	NULL
presence	NULL
of	NULL
a	NULL
50x	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
different	NULL
unlabeled	NULL
oligonucleotides	NULL
as	NULL
competitors	NULL
.	NULL

during	NULL
16	NULL
h	NULL
,	NULL
strongly	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
upper	NULL
NF	NULL
-	NULL
«	NULL
B	NULL
complexes	NULL
.	NULL

A	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
lower	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
could	NULL
also	NULL
be	NULL
detected	NULL
.	NULL

No	NULL
significant	NULL
variation	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
SRF	NULL
band	NULL
were	NULL
detected	NULL
upon	NULL
PDB	NULL
treat-ment	NULL
.	NULL

Very	NULL
interestingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
neutralizing	NULL
antiTNFa	NULL
mAb	NULL
strongly	NULL
inhibited	NULL
(	NULL
reproducibly	NULL
by	NULL
80-95	NULL
%	NULL
)	NULL
the	NULL
PDB-induced	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
upper	NULL
NF-	NULL
«	NULL
B	NULL
bands	NULL
and	NULL
prevented	NULL
the	NULL
small	NULL
variation	NULL
of	NULL
the	NULL
PDB-induced	NULL
expression	NULL
of	NULL
the	NULL
lower	NULL
NF-kB	NULL
band	NULL
.	NULL

This	NULL
blockade	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
the	NULL
PKC	NULL
inhibitor	NULL
,	NULL
staurosporine	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

CsA	NULL
also	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
and	NULL
this	NULL
inhibition	NULL
could	NULL
be	NULL
efficiently	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
TNFa	NULL
,	NULL
but	NULL
not	NULL
IL-2	NULL
.	NULL

Reproducible	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
different	NULL
donors	NULL
.	NULL

All	NULL
of	NULL
those	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
PDB	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
NF	NULL
-B	NULL
to	NULL
its	NULL
target	NULL
sequences	NULL
,	NULL
when	NULL
IL-2Ra	NULL
«	NULL
starts	NULL
to	NULL
peak	NULL
after	NULL
activation	NULL
,	NULL
is	NULL
almost	NULL
completely	NULL
mediated	NULL
by	NULL
the	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
the	NULL
subunit	NULL
composition	NULL
of	NULL
each	NULL
of	NULL
the	NULL
three	NULL
NF-	NULL
«	NULL
B-related	NULL
complexes	NULL
detected	NULL
,	NULL
supershifting	NULL
EMSAs	NULL
using	NULL
different	NULL
specific	NULL
anti-NF-	NULL
«	NULL
B	NULL
antisera	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

For	NULL
this	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
or	NULL
PDB-activated	NULL
T	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
specific	NULL
polyclonal	NULL
antisera	NULL
raised	NULL
against	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
:	NULL
p50	NULL
(	NULL
n/kB1	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
rel	NULL
A	NULL
)	NULL
,	NULL
or	NULL
c-Rel	NULL
.	NULL

As	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
upper	NULL
NF	NULL
-	NULL
«	NULL
B	NULL
band	NULL
was	NULL
supershifted	NULL
by	NULL
both	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
antisera	NULL
,	NULL
the	NULL
middle	NULL
band	NULL
by	NULL
both	NULL
anti-p50	NULL
and	NULL
anti-c-Rel	NULL
,	NULL
and	NULL
Regulation	NULL
of	NULL
IL-2Ra	NULL
and	NULL
NF-kB	NULL
by	NULL
PKC	NULL
in	NULL
T	NULL
Cells	NULL
PDB	NULL
CsA	NULL
3	NULL
TNFa	NULL
-	NULL
3	NULL
-	NULL
c	NULL
i	NULL
/	NULL
3	NULL
PoB	NULL
IL-2	NULL
w	NULL
tow	NULL
®	NULL
Pu	NULL
anti-	NULL
TNFo	NULL
.	NULL

3	NULL
202	NULL
+	NULL
Staurosporine	NULL
$	NULL
%	NULL
Srt	NULL
-	NULL
»	NULL
Srt	NULL
-	NULL
»	NULL
t	NULL
h	NULL
4	NULL
j	NULL
NF	NULL
.	NULL

«	NULL
B-	NULL
*	NULL
>	NULL
NF	NULL
x8-	NULL
)	NULL
I	NULL
NF	NULL
x6	NULL
NF	NULL
.	NULL

xB	NULL
-	NULL
#	NULL
»	NULL
(	NULL
ull	NULL
4	NULL
t	NULL
44	NULL
free	NULL
free	NULL
probe	NULL
-a	NULL
)	NULL
probe	NULL
-	NULL
»	NULL
}	NULL
0	NULL
_	NULL
0.05	NULL
0.1	NULL
0	NULL
_1	NULL
0.1	NULL
1	NULL
1.1	NULL
0.1	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
endogenous	NULL
TNFa	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
PDB	NULL
treatment	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PDB	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
CsA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
staurosporine	NULL
(	NULL
50	NULL
nm	NULL
)	NULL
,	NULL
TNFa	NULL
(	NULL
500	NULL
units/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
anti-TNF	NULL
mAb	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
during	NULL
16	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
(	NULL
P-labeled	NULL
)	NULL
of	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
absorbance	NULL
values	NULL
for	NULL
the	NULL
scanning	NULL
analysis	NULL
,	NULL
performed	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
exposition	NULL
,	NULL
of	NULL
the	NULL
two	NULL
upper	NULL
NF-kB	NULL
complexes	NULL
were	NULL
obtained	NULL
by	NULL
subtracting	NULL
the	NULL
value	NULL
of	NULL
the	NULL
control	NULL
lane	NULL
and	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

the	NULL
lower	NULL
band	NULL
was	NULL
only	NULL
supershifted	NULL
by	NULL
the	NULL
anti-p50	NULL
anti-serum	NULL
.	NULL

A	NULL
similar	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
lower	NULL
NF-kB	NULL
complex	NULL
in	NULL
assays	NULL
performed	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
constitutively	NULL
express	NULL
it	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

No	NULL
supershifting	NULL
was	NULL
detected	NULL
when	NULL
the	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
antibodies	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extract	NULL
or	NULL
when	NULL
an	NULL
irrelevant	NULL
antiserum	NULL
was	NULL
present	NULL
in	NULL
the	NULL
binding	NULL
mixture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Those	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
the	NULL
upper	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
p50-p65	NULL
heterodimers	NULL
,	NULL
the	NULL
middle	NULL
one	NULL
contains	NULL
p50-c-Rel	NULL
heterodimers	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
one	NULL
only	NULL
contains	NULL
p50	NULL
subunits	NULL
,	NULL
probably	NULL
as	NULL
p50	NULL
homodimers	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

To	NULL
test	NULL
if	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
active	NULL
NF-kB	NULL
proteins	NULL
complexed	NULL
with	NULL
the	NULL
«	NULL
kB	NULL
probe	NULL
in	NULL
the	NULL
different	NULL
conditions	NULL
of	NULL
activation	NULL
were	NULL
accompanied	NULL
with	NULL
variations	NULL
in	NULL
the	NULL
nuclear	NULL
or	NULL
cytoplasmic	NULL
levels	NULL
of	NULL
the	NULL
different	NULL
proteins	NULL
,	NULL
Western	NULL
blots	NULL
with	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
proteins	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
from	NULL
resting	NULL
or	NULL
PDB-activated	NULL
T	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
different	NULL
indicated	NULL
agents	NULL
)	NULL
,	NULL
were	NULL
blotted	NULL
with	NULL
anti-p50	NULL
,	NULL
anti-p65	NULL
,	NULL
or	NULL
anti-c-Rel	NULL
polyclonal	NULL
anti-bodies	NULL
.	NULL

As	NULL
can	NULL
be	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
p50	NULL
protein	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
was	NULL
high	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
EMSAs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
where	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
the	NULL
p50	NULL
containing	NULL
NF-kB	NULL
complex	NULL
was	NULL
detected	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
undetectable	NULL
levels	NULL
of	NULL
p65	NULL
protein	NULL
and	NULL
low	NULL
amounts	NULL
of	NULL
c-Rel	NULL
protein	NULL
were	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
EMSAs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
PDB	NULL
induced	NULL
the	NULL
presence	NULL
of	NULL
p65	NULL
and	NULL
a	NULL
strong	NULL
increase	NULL
of	NULL
c-Rel	NULL
proteins	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Interestingly	NULL
,	NULL
both	NULL
phenomena	NULL
were	NULL
strongly	NULL
inhibited	NULL
(	NULL
varying	NULL
80-95	NULL
%	NULL
between	NULL
different	NULL
do-nors	NULL
)	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
anti-TNFa	NULL
mAb	NULL
or	NULL
by	NULL
CsA	NULL
.	NULL

Addition	NULL
of	NULL
TNFa	NULL
was	NULL
able	NULL
to	NULL
completely	NULL
revert	NULL
CsA	NULL
inhibition	NULL
.	NULL

PDB	NULL
also	NULL
24427	NULL
CONTROL	NULL
PDB	NULL
o	NULL
wm	NULL
©	NULL
o	NULL
m	NULL
©	NULL
w-	NULL
©	NULL
'	NULL
;	NULL
©	NULL
@	NULL
'	NULL
r	NULL
,	NULL
a	NULL
a	NULL
o	NULL
a	NULL
a	NULL
o	NULL
anti-NF.xB	NULL
2	NULL
&	NULL
%	NULL
€	NULL
#	NULL
g	NULL
antibodies	NULL
|	NULL
§	NULL
§	NULL
&	NULL
|	NULL
!	NULL

§	NULL
&	NULL
§	NULL
we	NULL
Supershifted	NULL
Wi	NULL
#	NULL
hume	NULL
[	NULL
<	NULL
-	NULL
forms	NULL
ests	NULL
p65.p50	NULL
a	NULL
4=	NULL
c-rel.p50	NULL
®	NULL
-	NULL
moon	NULL
(	NULL
<	NULL
-	NULL
pS0.p50	NULL
#	NULL
%	NULL
bot	NULL
a	NULL
..	NULL
,	NULL
no	NULL
-	NULL
bose	NULL
free	NULL
«	NULL
-	NULL
probe	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
subunit	NULL
composition	NULL
of	NULL
the	NULL
different	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
PDB	NULL
during	NULL
16	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
fragment	NULL
(	NULL
P-labeled	NULL
)	NULL
of	NULL
IL-2R	NULL
«	NULL
promoter	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
the	NULL
binding	NULL
assays	NULL
were	NULL
preincubated	NULL
in	NULL
presence	NULL
of	NULL
specific	NULL
anti-p50	NULL
(	NULL
Serum	NULL
2	NULL
)	NULL
,	NULL
p65	NULL
or	NULL
c-Rel	NULL
(	NULL
Serum	NULL
1136	NULL
)	NULL
antisera	NULL
.	NULL

triggered	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
nuclear	NULL
p50	NULL
protein	NULL
,	NULL
which	NULL
was	NULL
slightly	NULL
inhibited	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
neutralizing	NULL
anti-TNFa	NULL
mAb	NULL
or	NULL
CsA	NULL
.	NULL

In	NULL
this	NULL
last	NULL
case	NULL
,	NULL
the	NULL
expression	NULL
was	NULL
also	NULL
recovered	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
TNFa	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
cytoplasmic	NULL
reservoirs	NULL
of	NULL
the	NULL
three	NULL
proteins	NULL
were	NULL
high	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
including	NULL
the	NULL
p105	NULL
precursor	NULL
of	NULL
p50	NULL
(	NULL
47	NULL
)	NULL
and	NULL
did	NULL
not	NULL
change	NULL
significantly	NULL
with	NULL
any	NULL
of	NULL
the	NULL
treatments	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

DISCUSSION	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
characteristic	NULL
events	NULL
triggered	NULL
by	NULL
PKC	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
detailed	NULL
mechanisms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
PKC	NULL
in	NULL
a	NULL
physiological	NULL
system	NULL
such	NULL
as	NULL
primary	NULL
cultures	NULL
of	NULL
normal	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
most	NULL
of	NULL
the	NULL
studies	NULL
on	NULL
NF-kB	NULL
regulation	NULL
have	NULL
been	NULL
performed	NULL
in	NULL
transformed	NULL
T	NULL
cell	NULL
lines	NULL
where	NULL
its	NULL
regulatory	NULL
mechanisms	NULL
can	NULL
not	NULL
faithfully	NULL
reflect	NULL
the	NULL
physiological	NULL
ones	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
by	NULL
phorbol	NULL
esters	NULL
in	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
strongly	NULL
induced	NULL
the	NULL
translocation	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
NF-kB	NULL
proteins	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
the	NULL
-290	NULL
to	NULL
-239	NULL
IL-2Ra	NULL
«	NULL
fragment	NULL
as	NULL
p50-p65	NULL
and	NULL
p50-c-Rel	NULL
heterodimers	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
PKC	NULL
activation	NULL
on	NULL
NF-kB	NULL
seems	NULL
to	NULL
be	NULL
mostly	NULL
indirect	NULL
and	NULL
mediated	NULL
by	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
,	NULL
since	NULL
it	NULL
could	NULL
be	NULL
almost	NULL
completely	NULL
inhibited	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
neutralizing	NULL
anti-TNFa	NULL
«	NULL
mAb	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
«	NULL
by	NULL
PKC	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
both	NULL
at	NULL
the	NULL
membrane	NULL
and	NULL
mRNA	NULL
levels	NULL
,	NULL
was	NULL
indirect	NULL
.	NULL

However	NULL
,	NULL
this	NULL
effect	NULL
was	NULL
mediated	NULL
by	NULL
the	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
and	NULL
IL-2	NULL
,	NULL
as	NULL
it	NULL
was	NULL
almost	NULL
totally	NULL
inhibited	NULL
by	NULL
neutralizing	NULL
anti-TNFa	NULL
or	NULL
anti-IL-2R	NULL
«	NULL
mAbs	NULL
.	NULL

Our	NULL
results	NULL
were	NULL
confirmed	NULL
by	NULL
evaluating	NULL
the	NULL
effect	NULL
of	NULL
their	NULL
addition	NULL
in	NULL
a	NULL
lymphokine-free	NULL
background	NULL
.	NULL

This	NULL
is	NULL
par	NULL
24428	NULL
NUCLEAR	NULL
EXTRACTS	NULL
CYTOPLASMIC	NULL
EXTRACTS	NULL
E	NULL
z	NULL
PDB	NULL
CsA	NULL
=	NULL
$	NULL
4	NULL
-	NULL
fsa	NULL
2	NULL
TNFa	NULL
2	NULL
we	NULL
TNFa	NULL
Q	NULL
-	NULL
C	NULL
}	NULL
anti-TNFo	NULL
3	NULL
tC	NULL
%	NULL
anti-TNFa	NULL
3	NULL
<	NULL
0	NULL
9	NULL
%	NULL
p5o	NULL
-	NULL
»	NULL
|	NULL
mee	NULL
8k	NULL
am	NULL
due	NULL
sa	NULL
|	NULL
.	NULL

D105	NULL
-	NULL
>	NULL
]	NULL
04-07-06	NULL
-	NULL
pso-	NULL
»	NULL
|	NULL
1	NULL
I	NULL
pss	NULL
-	NULL
»	NULL
|	NULL
RNN	NULL
AEE	NULL
p65	NULL
-	NULL
»	NULL
]	NULL
”	NULL
ﬂ	NULL
“	NULL
0	NULL
0	NULL
0	NULL
|	NULL
1.4	NULL
~-	NULL
RRE	NULL
|	NULL
..-	NULL
0.1	NULL
0.3	NULL
0.1	NULL
1	NULL
1.1	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
endogenous	NULL
TNF	NULL
«	NULL
in	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
levels	NULL
of	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
of	NULL
T	NULL
cells	NULL
activated	NULL
with	NULL
PDB	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
absence	NULL
or	NULL
in	NULL
presence	NULL
of	NULL
PDB	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
CsA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
TNFa	NULL
(	NULL
500	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
anti-TNF	NULL
«	NULL
mAb	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
during	NULL
16	NULL
h.	NULL
After	NULL
this	NULL
incubation	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
obtained	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
specific	NULL
anti-p50	NULL
(	NULL
Serum	NULL
1141	NULL
)	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
c-Rel	NULL
(	NULL
Serum	NULL
265	NULL
)	NULL
antisera	NULL
.	NULL

The	NULL
absorbance	NULL
values	NULL
for	NULL
the	NULL
scanning	NULL
analysis	NULL
of	NULL
the	NULL
bands	NULL
(	NULL
performed	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
exposition	NULL
)	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

All	NULL
values	NULL
were	NULL
referred	NULL
to	NULL
the	NULL
absorbance	NULL
of	NULL
the	NULL
PDB	NULL
lane	NULL
.	NULL

The	NULL
absorbance	NULL
values	NULL
of	NULL
the	NULL
bands	NULL
obtained	NULL
with	NULL
cytoplasmic	NULL
extracts	NULL
are	NULL
not	NULL
shown	NULL
,	NULL
because	NULL
the	NULL
slight	NULL
changes	NULL
observed	NULL
were	NULL
not	NULL
reproducible	NULL
between	NULL
different	NULL
experiments	NULL
.	NULL

ticularly	NULL
important	NULL
in	NULL
our	NULL
system	NULL
,	NULL
because	NULL
we	NULL
have	NULL
used	NULL
primary	NULL
T	NULL
cell	NULL
cultures	NULL
that	NULL
have	NULL
a	NULL
variable	NULL
response	NULL
to	NULL
activation	NULL
(	NULL
and	NULL
concomitantly	NULL
different	NULL
levels	NULL
of	NULL
endogenous	NULL
lympho-kines	NULL
)	NULL
between	NULL
different	NULL
donors	NULL
.	NULL

This	NULL
was	NULL
achieved	NULL
with	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
CsA	NULL
,	NULL
which	NULL
inhibits	NULL
the	NULL
endogenous	NULL
secretion	NULL
of	NULL
lymphokines	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
CsA	NULL
inhibited	NULL
the	NULL
PDB-triggered	NULL
NF	NULL
-B	NULL
activation	NULL
and	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
TNFa	NULL
alone	NULL
could	NULL
prevent	NULL
this	NULL
inhibition	NULL
.	NULL

Similarly	NULL
,	NULL
CsA	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
«	NULL
,	NULL
and	NULL
either	NULL
TNFa	NULL
or	NULL
IL-2	NULL
could	NULL
recover	NULL
the	NULL
IL-2Ra	NULL
expression	NULL
,	NULL
although	NULL
not	NULL
entirely	NULL
.	NULL

A	NULL
total	NULL
recovery	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
was	NULL
only	NULL
seen	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
TNFa	NULL
and	NULL
IL-2	NULL
.	NULL

Our	NULL
results	NULL
may	NULL
explain	NULL
why	NULL
the	NULL
effects	NULL
of	NULL
PDB	NULL
and	NULL
TNFa	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
greatly	NULL
overlapping	NULL
(	NULL
10	NULL
,	NULL
24-26	NULL
,	NULL
34	NULL
)	NULL
.	NULL

A	NULL
study	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
different	NULL
deletions	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
indicated	NULL
that	NULL
their	NULL
quantitative	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
and	NULL
TNFa	NULL
correlate	NULL
quite	NULL
well	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
they	NULL
showed	NULL
that	NULL
the	NULL
enhancer	NULL
region	NULL
responsible	NULL
for	NULL
the	NULL
action	NULL
of	NULL
phorbol	NULL
esters	NULL
and	NULL
TNFa	NULL
is	NULL
located	NULL
between	NULL
the	NULL
-291	NULL
and	NULL
-245	NULL
nucleotides	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
24	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
a	NULL
kB	NULL
consensus	NULL
recognized	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
also	NULL
activated	NULL
by	NULL
PKC	NULL
and	NULL
TNFa	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
PDB	NULL
on	NULL
IL-2Ra	NULL
expression	NULL
or	NULL
NF	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
human	NULL
purified	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
endogenous	NULL
activity	NULL
of	NULL
TNFa	NULL
,	NULL
may	NULL
explain	NULL
those	NULL
close	NULL
correlations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
endogenously	NULL
secreted	NULL
IL-2	NULL
has	NULL
also	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
PDB-induced	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
,	NULL
since	NULL
it	NULL
could	NULL
be	NULL
greatly	NULL
inhibited	NULL
by	NULL
neutralizing	NULL
anti-IL-2R	NULL
«	NULL
mAbs	NULL
.	NULL

Moreover	NULL
,	NULL
IL-2	NULL
partially	NULL
rescued	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
from	NULL
CsA	NULL
inhibition	NULL
,	NULL
similar	NULL
to	NULL
TNFa	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
PKC	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
triggers	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
«	NULL
but	NULL
the	NULL
quantitative	NULL
regulation	NULL
of	NULL
its	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Regulation	NULL
of	NULL
IL-2Ra	NULL
and	NULL
NF-kB	NULL
by	NULL
PKC	NULL
in	NULL
T	NULL
Cells	NULL
TNFa	NULL
and	NULL
IL-2	NULL
present	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

Interestingly	NULL
,	NULL
both	NULL
anti-TNFa	NULL
«	NULL
and	NULL
anti-IL-2R	NULL
«	NULL
mAbs	NULL
inhibited	NULL
each	NULL
one	NULL
more	NULL
than	NULL
50	NULL
%	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
.	NULL

This	NULL
seems	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
of	NULL
completely	NULL
unrelated	NULL
effects	NULL
of	NULL
TNFa	NULL
and	NULL
IL-2	NULL
on	NULL
the	NULL
different	NULL
T	NULL
cell	NULL
subpopulations	NULL
present	NULL
in	NULL
the	NULL
cultures	NULL
.	NULL

Rather	NULL
,	NULL
this	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
interconnected	NULL
loop	NULL
of	NULL
amplification	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
«	NULL
chain	NULL
by	NULL
the	NULL
two	NULL
lymphokines	NULL
.	NULL

Another	NULL
remarkable	NULL
correlation	NULL
that	NULL
can	NULL
be	NULL
deduced	NULL
from	NULL
our	NULL
results	NULL
is	NULL
the	NULL
similar	NULL
behavior	NULL
of	NULL
IL-2Ra	NULL
«	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
regu-lation	NULL
.	NULL

Both	NULL
phenomena	NULL
are	NULL
strongly	NULL
inhibited	NULL
by	NULL
an	NULL
antiTNFa	NULL
mAb	NULL
or	NULL
CsA	NULL
,	NULL
and	NULL
,	NULL
in	NULL
this	NULL
last	NULL
case	NULL
,	NULL
the	NULL
exogenous	NULL
addition	NULL
of	NULL
TNFa	NULL
can	NULL
restore	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
.	NULL

This	NULL
close	NULL
correlation	NULL
supports	NULL
that	NULL
NF-kB	NULL
has	NULL
a	NULL
relevant	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
other	NULL
groups	NULL
by	NULL
transfecting	NULL
different	NULL
fragments	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
into	NULL
T	NULL
cell	NULL
lines	NULL
or	NULL
T	NULL
cell	NULL
blasts	NULL
(	NULL
12	NULL
,	NULL
15	NULL
,	NULL
18	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
or	NULL
by	NULL
cotransfecting	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
fragments	NULL
together	NULL
with	NULL
the	NULL
c-rel	NULL
cDNA	NULL
NF-kB	NULL
subunit	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
previously	NULL
described	NULL
transcriptional	NULL
enhancing	NULL
effect	NULL
of	NULL
IL-2	NULL
in	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
,	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
NF	NULL
-B	NULL
,	NULL
as	NULL
no	NULL
translocation	NULL
of	NULL
this	NULL
factor	NULL
was	NULL
induced	NULL
by	NULL
IL-2	NULL
despite	NULL
having	NULL
a	NULL
strong	NULL
effect	NULL
in	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
levels	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
disagreement	NULL
with	NULL
previous	NULL
reports	NULL
showing	NULL
that	NULL
IL-2	NULL
can	NULL
induce	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
discrepancy	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
but	NULL
it	NULL
may	NULL
lie	NULL
in	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
use	NULL
high	NULL
concentrations	NULL
of	NULL
IL-2	NULL
in	NULL
their	NULL
assay	NULL
,	NULL
without	NULL
addressing	NULL
the	NULL
contribution	NULL
of	NULL
endogenously	NULL
secreted	NULL
lymphokines	NULL
.	NULL

Since	NULL
it	NULL
is	NULL
well	NULL
known	NULL
that	NULL
IL-2	NULL
at	NULL
those	NULL
concentrations	NULL
may	NULL
induce	NULL
TNFa	NULL
(	NULL
51	NULL
)	NULL
,	NULL
it	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
possible	NULL
that	NULL
the	NULL
effect	NULL
attributed	NULL
to	NULL
IL-2	NULL
would	NULL
be	NULL
in	NULL
fact	NULL
an	NULL
IL-2-induced	NULL
TNFa-medi-ated	NULL
effect	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
has	NULL
been	NULL
controver-sial	NULL
.	NULL

Thus	NULL
,	NULL
either	NULL
a	NULL
strong	NULL
inhibitory	NULL
effect	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
or	NULL
no	NULL
effect	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
of	NULL
CsA	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

As	NULL
our	NULL
experiments	NULL
now	NULL
suggest	NULL
,	NULL
those	NULL
discrepancies	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
endogenous	NULL
cyto-kines	NULL
in	NULL
the	NULL
different	NULL
systems	NULL
(	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
different	NULL
timings	NULL
or	NULL
different	NULL
stimuli	NULL
)	NULL
used	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
described	NULL
a	NULL
partial	NULL
inhibitory	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
by	NULL
phytohemagglutinin	NULL
plus	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
in	NULL
both	NULL
primary	NULL
and	NULL
transformed	NULL
T	NULL
cells	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
,	NULL
results	NULL
that	NULL
would	NULL
be	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
data	NULL
.	NULL

However	NULL
,	NULL
they	NULL
do	NULL
not	NULL
address	NULL
the	NULL
relevance	NULL
of	NULL
endogenous	NULL
lymphokines	NULL
as	NULL
we	NULL
have	NULL
done	NULL
.	NULL

Alternatively	NULL
,	NULL
CsA	NULL
could	NULL
directly	NULL
affect	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
preventing	NULL
its	NULL
transport	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
has	NULL
been	NULL
described	NULL
for	NULL
NF-AT	NULL
(	NULL
58	NULL
)	NULL
,	NULL
or	NULL
by	NULL
inhibiting	NULL
the	NULL
activity	NULL
of	NULL
some	NULL
of	NULL
the	NULL
PKC	NULL
subtypes	NULL
,	NULL
as	NULL
recently	NULL
reported	NULL
(	NULL
59	NULL
)	NULL
.	NULL

However	NULL
,	NULL
those	NULL
effects	NULL
are	NULL
unlikely	NULL
to	NULL
explain	NULL
the	NULL
observed	NULL
blockade	NULL
of	NULL
CsA	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
since	NULL
those	NULL
inhibitions	NULL
were	NULL
prevented	NULL
by	NULL
the	NULL
exogenous	NULL
addition	NULL
of	NULL
TNFa	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
PKC	NULL
activation	NULL
induces	NULL
NF-kB	NULL
activation	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
as	NULL
heterodimers	NULL
with	NULL
p50	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cytoplasmic	NULL
levels	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
proteins	NULL
seemed	NULL
to	NULL
remain	NULL
unaltered	NULL
by	NULL
the	NULL
treatments	NULL
used	NULL
,	NULL
even	NULL
those	NULL
that	NULL
,	NULL
by	NULL
inhibiting	NULL
the	NULL
action	NULL
of	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
,	NULL
caused	NULL
a	NULL
strong	NULL
impairment	NULL
of	NULL
nuclear	NULL
expression	NULL
of	NULL
p65	NULL
or	NULL
c-Rel	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
permissive	NULL
effect	NULL
of	NULL
the	NULL
endogenous	NULL
TNFa	NULL
on	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-kB	NULL
seems	NULL
to	NULL
be	NULL
exerted	NULL
in	NULL
its	NULL
transport	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
variations	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
p65	NULL
NF-kB	NULL
mRNA	NULL
by	NULL
antiTNFa	NULL
or	NULL
CsA*	NULL
*F.	NULL
X.	NULL
Pimentel-Muinos	NULL
,	NULL
and	NULL
M.	NULL
Fresno	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

Regulation	NULL
of	NULL
IL-2Ra	NULL
and	NULL
NF-kB	NULL
by	NULL
PKC	NULL
in	NULL
T	NULL
Cells	NULL
24429	NULL
17	NULL
.	NULL

Tan	NULL
,	NULL
T.	NULL
,	NULL
Huang	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
We	NULL
have	NULL
used	NULL
a	NULL
rather	NULL
long	NULL
«	NULL
B	NULL
probe	NULL
to	NULL
perform	NULL
the	NULL
EMSAs	NULL
.	NULL

The	NULL
probe	NULL
contains	NULL
the	NULL
<	NULL
B	NULL
element	NULL
present	NULL
in	NULL
the	NULL
IL-Z2Ra	NULL
promoter	NULL
(	NULL
located	NULL
between	NULL
nucleotides	NULL
-268	NULL
and	NULL
-257	NULL
)	NULL
,	NULL
but	NULL
it	NULL
also	NULL
contains	NULL
other	NULL
surrounding	NULL
sequences	NULL
(	NULL
-290	NULL
to	NULL
-239	NULL
)	NULL
that	NULL
had	NULL
been	NULL
previously	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
IL-2Ra	NULL
.	NULL

Those	NULL
sequences	NULL
include	NULL
the	NULL
target	NULL
for	NULL
the	NULL
SRF	NULL
(	NULL
-253	NULL
to	NULL
-244	NULL
)	NULL
that	NULL
,	NULL
when	NULL
mutated	NULL
or	NULL
deleted	NULL
,	NULL
abrogates	NULL
the	NULL
PKC-triggered	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
under	NULL
its	NULL
control	NULL
,	NULL
transfected	NULL
to	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
15	NULL
,	NULL
44	NULL
)	NULL
.	NULL

This	NULL
region	NULL
also	NULL
contains	NULL
a	NULL
consensus	NULL
site	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
SP1	NULL
factor	NULL
(	NULL
-245	NULL
to	NULL
-240	NULL
)	NULL
that	NULL
has	NULL
been	NULL
involved	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
target	NULL
sequence	NULL
for	NULL
an	NULL
unknown	NULL
factor	NULL
called	NULL
RA	NULL
(	NULL
44	NULL
)	NULL
is	NULL
also	NULL
located	NULL
in	NULL
this	NULL
fragment	NULL
(	NULL
-290	NULL
to	NULL
-269	NULL
)	NULL
that	NULL
,	NULL
when	NULL
mutated	NULL
,	NULL
either	NULL
abrogates	NULL
or	NULL
increases	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
transfected	NULL
cell	NULL
type	NULL
,	NULL
the	NULL
transcription	NULL
directed	NULL
by	NULL
fragments	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
44	NULL
)	NULL
.	NULL

However	NULL
,	NULL
although	NULL
we	NULL
detected	NULL
the	NULL
SRF	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
resting	NULL
and	NULL
PKC-activated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
putative	NULL
RA	NULL
or	NULL
SP1	NULL
binding	NULL
activities	NULL
were	NULL
not	NULL
identified	NULL
by	NULL
competition	NULL
analyses	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
neither	NULL
the	NULL
mobility	NULL
nor	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
SRF	NULL
factor	NULL
varied	NULL
upon	NULL
PKC	NULL
activation	NULL
or	NULL
with	NULL
the	NULL
different	NULL
treatment	NULL
used	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
does	NULL
not	NULL
have	NULL
a	NULL
relevant	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
transcription	NULL
during	NULL
PKC	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

All	NULL
those	NULL
discrepancies	NULL
may	NULL
lie	NULL
in	NULL
their	NULL
use	NULL
of	NULL
T	NULL
cell	NULL
lines	NULL
instead	NULL
of	NULL
purified	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
represents	NULL
a	NULL
more	NULL
physiological	NULL
source	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
PKC	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
induces	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
p65	NULL
and	NULL
c-Rel	NULL
proteins	NULL
,	NULL
where	NULL
they	NULL
bind	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
induction	NULL
,	NULL
as	NULL
well	NULL
as	NULL
one	NULL
of	NULL
the	NULL
most	NULL
characteristic	NULL
T	NULL
cell	NULL
activation	NULL
events	NULL
that	NULL
had	NULL
been	NULL
previously	NULL
directly	NULL
linked	NULL
to	NULL
PKC	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
the	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
,	NULL
are	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
mainly	NULL
due	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
endogenously	NULL
secreted	NULL
TNFa	NULL
.	NULL

Therefore	NULL
,	NULL
TNFa	NULL
emerges	NULL
as	NULL
one	NULL
of	NULL
the	NULL
major	NULL
inducers	NULL
of	NULL
IL-2Ra	NULL
«	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
playing	NULL
a	NULL
previously	NULL
underestimated	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

REFERENCES	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
263-274	NULL
.	NULL

Truneh	NULL
,	NULL
A.	NULL
,	NULL
Albert	NULL
,	NULL
F.	NULL
,	NULL
Golstein	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Schmitt-Verhulst	NULL
,	NULL
A.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
.	NULL

le	NULL
18	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
,	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

N.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4067-4075	NULL
Freimuth	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3064-3068	NULL
.	NULL

Hsiou-Chi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5	NULL
,	NULL
477-487	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1529-1533	NULL
.	NULL

Lernbecher	NULL
,	NULL
T.	NULL
,	NULL
Miller	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
767-770	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
135-140	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
2331-2335	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
3121-3128	NULL
Hazan	NULL
,	NULL
U.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Yssel	NULL
,	NULL
H.	NULL
,	NULL
Vireli-zier	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
7861-7865	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
10028-10032	NULL
Jamieson	NULL
,	NULL
C.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
416-420	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Tan	NULL
,	NULL
T.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
1696-1700	NULL
Vilcek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7313-7316	NULL
Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Kao	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
and	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
937-953	NULL
Steffen	NULL
,	NULL
M.	NULL
,	NULL
Ottmann	NULL
,	NULL
O.	NULL
G.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
M.	NULL
A.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
2621-2624	NULL
English	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Weaver	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7108-7113	NULL
Lee	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Truneh	NULL
,	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Tsang	NULL
,	NULL
K.	NULL
Y	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

139	NULL
,	NULL
1935-1938	NULL
Scheurich	NULL
,	NULL
P.	NULL
,	NULL
Thoma	NULL
,	NULL
B.	NULL
,	NULL
Ucer	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Pfizenmaier	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

188	NULL
,	NULL
1786-1790	NULL
Yokota	NULL
,	NULL
S.	NULL
,	NULL
Geppert	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
and	NULL
Lipsky	NULL
,	NULL
P.	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
531-536	NULL
Mufioz-Fernéndez	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Pimentel-Muifios	NULL
,	NULL
F.	NULL
X.	NULL
,	NULL
Alonso	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Campanero	NULL
,	NULL
M.	NULL
,	NULL
S	NULL
&	NULL
nchez-Madrid	NULL
,	NULL
F.	NULL
,	NULL
Silva	NULL
,	NULL
A.	NULL
,	NULL
Alonso	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20	NULL
,	NULL
605-610	NULL
Pimentel-Muinfios	NULL
,	NULL
F.	NULL
X.	NULL
,	NULL
Munoz-Ferngndez	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
5714-5722	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
Werner	NULL
,	NULL
C.	NULL
,	NULL
Klouda	NULL
,	NULL
P.	NULL
T.	NULL
,	NULL
Correa	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Jeannet	NULL
,	NULL
M.	NULL
(	NULL
1977	NULL
)	NULL
Tissue	NULL
Antigens	NULL
9	NULL
,	NULL
227-229	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Roman	NULL
,	NULL
D	NULL
,	NULL
G.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
1830-1834	NULL
313	NULL
,	NULL
318-320	NULL
45	NULL
.	NULL

Sigal	NULL
,	NULL
N.	NULL
H.	NULL
,	NULL
and	NULL
Dumont	NULL
,	NULL
F.	NULL
J..	NULL
(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
519-560	NULL
3	NULL
.	NULL

Altman	NULL
,	NULL
A.	NULL
,	NULL
Coggeshall	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Mustelin	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

48	NULL
,	NULL
46	NULL
.	NULL

Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
642-647	NULL
227-360	NULL
47	NULL
.	NULL

Gosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
4	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
355-361	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
5	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
224	NULL
,	NULL
1312-1316	NULL
48	NULL
.	NULL

Welte	NULL
,	NULL
K.	NULL
,	NULL
Andreeff	NULL
,	NULL
M.	NULL
,	NULL
Platzer	NULL
,	NULL
E.	NULL
,	NULL
Holloway	NULL
,	NULL
K.	NULL
,	NULL
Rubin	NULL
,	NULL
B.	NULL
Y.	NULL
,	NULL
Moore	NULL
,	NULL
M.	NULL
A.	NULL
S.	NULL
,	NULL
6	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Minami	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
5-8	NULL
and	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
1390-1403	NULL
7	NULL
.	NULL

Minami	NULL
,	NULL
Y.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Im-	NULL
_	NULL
49	NULL
.	NULL

Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Drogula	NULL
,	NULL
C.	NULL
,	NULL
Krinke	NULL
,	NULL
M.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
munol	NULL
,	NULL
11	NULL
,	NULL
245-268	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
Tsudo	NULL
,	NULL
M.	NULL
,	NULL
Minamoto	NULL
,	NULL
S.	NULL
,	NULL
Kono	NULL
,	NULL
T.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
Miyasaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
551-556	NULL
9	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Asao	NULL
,	NULL
H.	NULL
,	NULL
Ohtani	NULL
,	NULL
K.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Munakata	NULL
,	NULL
H.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
379-382	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Krinke	NULL
,	NULL
M.	NULL
,	NULL
Noguchi	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Cunningham	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
go	NULL
»	NULL
10	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
4230-4234	NULL
Arima	NULL
,	NULL
N.	NULL
,	NULL
Kuziel	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Grdina	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
83-91	NULL
Lorre	NULL
,	NULL
K.	NULL
,	NULL
Fransen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Ceuppens	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Eur	NULL
.	NULL

Cytokine	NULL
Network	NULL
8	NULL
,	NULL
321-330	NULL
Reed	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Abidi	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Alpers	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Hoover	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Robb	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

187	NULL
,	NULL
150-154	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

138	NULL
,	NULL
3054-3061	NULL
53	NULL
.	NULL

Hemar	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Dautry-Varsat	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20	NULL
,	NULL
2620-2635	NULL
11	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
_	NULL
54	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
Andrus	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

163	NULL
,	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
6281-6285	NULL
922-937	NULL
12	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Bihnlein	NULL
,	NULL
E.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

55	NULL
.	NULL

Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Matkovich	NULL
,	NULL
D	NULL
,	NULL
A.	NULL
,	NULL
Collier	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kwok	NULL
,	NULL
P.	NULL
,	NULL
Dumont	NULL
,	NULL
F.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
4468-4472	NULL
Degudicibus	NULL
,	NULL
S.	NULL
,	NULL
Siekierka	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Chin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hutchinson	NULL
,	NULL
N.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

13	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
718-726	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
827-836	NULL
56	NULL
.	NULL

Schmidt	NULL
,	NULL
A.	NULL
,	NULL
Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

64	NULL
,	NULL
4037-14	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Wolf	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
4041	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
47-56	NULL
57	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
P.	NULL
,	NULL
Inaba	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Steinman	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

15	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Med	NULL
.	NULL

172	NULL
,	NULL
1869-1872	NULL
Leonard	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
850-853	NULL
58	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthésy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
.	NULL

16	NULL
.	NULL

Hemar	NULL
,	NULL
A.	NULL
,	NULL
Barrand	NULL
,	NULL
P.	NULL
,	NULL
Ferrer	NULL
,	NULL
M.	NULL
,	NULL
Cornet	NULL
,	NULL
V.	NULL
,	NULL
Buttin	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dautry-Varsat	NULL
,	NULL
852	NULL
,	NULL
803-807	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
1097~1105	NULL
59	NULL
.	NULL

Szamel	NULL
,	NULL
M.	NULL
,	NULL
Bartels	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Resch	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
3072-3081	NULL

